Effectiveness and Safety of Linezolid Versus Vancomycin, Teicoplanin, or Daptomycin against Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia: A Systematic Review and Meta-Analysis
Vancomycin (VCM) and daptomycin (DAP) are standard therapies for methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) bacteremia, despite concerns regarding clinical utility and growing resistance. Linezolid (LZD) affords superior tissue penetration to VCM or DAP and has been succes...
Main Authors: | Hitoshi Kawasuji, Kentaro Nagaoka, Yasuhiro Tsuji, Kou Kimoto, Yusuke Takegoshi, Makito Kaneda, Yushi Murai, Haruka Karaushi, Kotaro Mitsutake, Yoshihiro Yamamoto |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/12/4/697 |
Similar Items
-
Treatment of bacteremia by vancomycin-resistant Enterococcus with daptomycin versus linezolid: a systematic review and meta-analyses
by: Caicedo-Ochoa, Edgar Yaset, et al.
Published: (2017-01-01) -
Breakthrough daptomycin-, linezolid-, vancomycin-resistant Enterococcus faecium bacteremia during protracted daptomycin therapy: A case report
by: Nathan B. Pincus, et al.
Published: (2022-01-01) -
Initially Reduced Linezolid Dosing Regimen to Prevent Thrombocytopenia in Hemodialysis Patients
by: Hitoshi Kawasuji, et al.
Published: (2021-04-01) -
Comparing the Outcomes of Ceftaroline plus Vancomycin or Daptomycin Combination Therapy versus Vancomycin or Daptomycin Monotherapy in Adults with Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia—A Meta-Analysis
by: Chienhsiu Huang, et al.
Published: (2022-08-01) -
High Incidence of Metastatic Infections in Panton-Valentine Leucocidin-Negative, Community-Acquired Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia: An 11-Year Retrospective Study in Japan
by: Hitoshi Kawasuji, et al.
Published: (2023-10-01)